John M. Climaco
Chief Executive Officer at CNS Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: CNS Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Moleculin Biotech Inc. October 9, 202679.1%
-
CNS Pharmaceuticals Inc. November 17, 202575.5%
-
Moleculin Biotech Inc. August 18, 202575.9%
-
Moleculin Biotech Inc. October 24, 202479.4%
-
CNS Pharmaceuticals Inc. April 30, 202487.0%
-
CNS Pharmaceuticals Inc. September 14, 202389.5%
-
Moleculin Biotech Inc. May 25, 202382.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 1, 2024 | CNS Pharmaceuticals Inc. | Open-market purchase | +166,666 | $0.30 | $50,000 |
| Aug 16, 2023 | CNS Pharmaceuticals Inc. | Open-market purchase | +2,750 | $1.80 | $4,950 |
| Apr 28, 2023 | CNS Pharmaceuticals Inc. | Option exercise | +1,250 | — | — |
| Apr 12, 2023 | CNS Pharmaceuticals Inc. | Open-market purchase | +15,000 | $0.69 | $10,350 |
Questions about John M. Climaco
What boards is John M. Climaco on?
John M. Climaco sits on the boards of CNS Pharmaceuticals Inc. and Moleculin Biotech Inc.
Has John M. Climaco been a CEO?
Yes — John M. Climaco was CEO of CNS Pharmaceuticals Inc. (Until January 2026).
How long has John M. Climaco served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.